疫苗技術正在加速演化，mRNA只是開始。這一集聚焦一個被低估的小分子：Mildronate，在新一代脂質體配方中的策略角色。它如何影響劑量設計、安全性與製程效率？這場看不見的藥物遞送革命，或許將重塑疫苗市場版圖。
The mRNA wave was just the beginning. This episode examines how Mildronate—an often-overlooked small molecule—might play a strategic role in next-gen liposomal vaccines. We dive into formulation insights, delivery precision, and clinical implications that could reshape the future of immunization tech.
📝https://pubmed.ncbi.nlm.nih.gov/38798555/

https://pubmed.ncbi.nlm.nih.gov/39151414/

 -

TBAL 台灣活性脂質股份有限公司

官網  ⁠⁠⁠https://www.t-bal.com/⁠⁠⁠

粉絲臉書團  ⁠⁠⁠https://www.facebook.com/TBAL2017⁠⁠⁠

YOUTUBE ⁠ ⁠⁠https://www.youtube.com/@Taiwan-BioActive-Lipid⁠⁠⁠

The recipient's phone：+886-4-2247-6758

Customer service email：⁠⁠t-bal_2@t-bal.com.tw⁠⁠